Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies
Clinical trial NCT03082677 · COMPLETED
Trial details
- NCT number
- NCT03082677
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2021-09-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.